{
  "question_stem": {
    "en": "A 43-year-old man comes to the emergency department due to 2 weeks of intermittent fevers, malaise, and headaches. He has a history of HIV and has not been taking his antiretroviral drugs recently. Five years ago, the patient spent a year in jail. Temperature is 38.2 C (100.8 F). Cerebrospinal fluid (CSF) analysis shows markedly elevated protein and low glucose, and CSF cultures grow *Mycobacterium tuberculosis*. Resistance testing shows the following:\n\nRifampin\tsensitive\nIsoniazid\tsensitive\nPyrazinamide\tsensitive\nEthambutol\tsensitive\nStreptomycin\tresistant\nMoxifloxacin\tsensitive",
    "zh": "一名43岁男性因间歇性发热、不适和头痛两周就诊于急诊科。 他有HIV病史，近期未服用抗逆转录病毒药物。 五年前，该患者在监狱待了一年。 体温38.2摄氏度（100.8华氏度）。 脑脊液（CSF）分析显示蛋白显着升高和葡萄糖降低，CSF培养显示*结核分枝杆菌*生长。 耐药性检测显示如下：\n\n利福平\t敏感\n异烟肼\t敏感\n吡嗪酰胺\t敏感\n乙胺丁醇\t敏感\n链霉素\t耐药\n莫西沙星\t敏感"
  },
  "question": {
    "en": "Which of the following best explains the resistance pattern seen in these bacteria?",
    "zh": "以下哪项最能解释这些细菌中看到的耐药性模式？"
  },
  "options": {
    "A": {
      "en": "Altered structure of bacterial ribosomal proteins",
      "zh": "细菌核糖体蛋白的结构改变"
    },
    "B": {
      "en": "Altered structure of enzymes involved in DNA winding-unwinding",
      "zh": "参与DNA缠绕-解开的酶的结构改变"
    },
    "C": {
      "en": "Altered structure of enzymes involved in RNA synthesis",
      "zh": "参与RNA合成的酶的结构改变"
    },
    "D": {
      "en": "Decreased activity of bacterial catalase-peroxidase",
      "zh": "细菌过氧化氢酶-过氧化物酶活性降低"
    },
    "E": {
      "en": "Increased activity of enzymes involved in cell wall polysaccharide synthesis",
      "zh": "参与细胞壁多糖合成的酶的活性增加"
    }
  },
  "correct_answer": "A",
  "explanation": {
    "en": "This patient with HIV has fever, headache, and central nervous system (eg, spinal fluid) culture growing *Mycobacterium tuberculosis*, consistent with *M tuberculosis* meningitis. Initial management is best accomplished through combination therapy with isoniazid (INH), rifampin, pyrazinamide, and either an injectable aminoglycoside or a fluoroquinolone.\n\n**Streptomycin** is one of the older drugs in the aminoglycoside family; therefore, bacterial resistance to this antibiotic is widespread, resulting in its current usage being limited mainly to the treatment of tuberculosis, plague, and tularemia. Like other aminoglycosides, streptomycin can be administered only parenterally. It works by interfering with the 16s rRNA of the bacterial **30S ribosomal subunit**, thereby preventing bacterial protein synthesis. Mutations of the genes that encode ribosomal proteins are responsible for aminoglycoside resistance because they lead to modifications in the ribosomal binding sites for these drugs. Other resistance mechanisms to aminoglycosides include aminoglycoside-modifying enzymes (eg, transferases) and mutated porins.\n\n(Choice B) Structural alteration of enzymes involved in DNA winding-unwinding is the means by which many microorganisms become resistant to fluoroquinolone antibiotics. Fluoroquinolones inhibit the bacterial enzymes because they lead to modifications in the ribosomal binding sites for these drugs. Other resistance mechanisms to aminoglycosides include aminoglycoside-modifying enzymes (eg, transferases) and mutated porins.\n\n(Choice C) Structural alteration of enzymes involved in RNA synthesis is the mechanism through which organisms become resistant to rifampin. Rifampin inhibits the bacterial DNA-dependent RNA polymerase, thereby preventing the transcription of DNA into mRNA.\n\n(Choice D) Decreased activity of bacterial catalase-peroxidase is a mechanism of mycobacterial resistance to INH. Mycobacterial catalase-peroxidase is required for the initial enzymatic conversion of INH to its active metabolite within the mycobacterial cells; without this enzyme, INH is unable to inhibit mycobacterial mycolic acid synthesis.\n\n(Choice E) Increased activity of enzymes involved in cell wall polysaccharide synthesis is the means by which mycobacteria develop resistance to ethambutol. Ethambutol interferes specifically with mycobacterial peptidoglycan cell wall synthesis, possibly through inhibition of arabinosyl transferase. This drug is ineffective against organisms other than mycobacteria.\n\nEducational objective:\n- The aminoglycoside streptomycin inhibits protein synthesis by inactivating the 30S (small) ribosomal subunit.\n- Decreased activity of bacterial catalase-peroxidase is a mechanism of mycobacterial resistance to isoniazid.\n- Structural alteration of enzymes involved in RNA synthesis (DNA-dependent RNA polymerase) is the mechanism through which organisms become resistant to rifampin.",
    "zh": "该HIV感染患者出现发热、头痛，中枢神经系统（例如，脑脊液）培养显示*结核分枝杆菌*生长，与*结核分枝杆菌*脑膜炎一致。 最佳初始治疗方法是通过异烟肼 (INH)、利福平、吡嗪酰胺，以及注射用氨基糖苷类药物或氟喹诺酮类药物的联合治疗。\n\n**链霉素**是氨基糖苷类家族中较早的药物之一； 因此，这种抗生素的细菌耐药性很普遍，导致其目前的使用主要限于治疗结核病、鼠疫和土拉热。 与其他氨基糖苷类药物一样，链霉素只能通过肠外途径给药。 它的作用是干扰细菌**30S核糖体亚基**的16s rRNA，从而阻止细菌蛋白质的合成。 编码核糖体蛋白的基因突变是氨基糖苷类耐药性的原因，因为它们会导致这些药物的核糖体结合位点发生改变。 氨基糖苷类药物的其他耐药机制包括氨基糖苷修饰酶（例如，转移酶）和突变的孔蛋白。\n\n（选项B）参与DNA缠绕-解开的酶的结构改变是许多微生物对氟喹诺酮类抗生素产生耐药性的方式。 氟喹诺酮类药物抑制细菌酶，因为它们导致这些药物的核糖体结合位点发生改变。 氨基糖苷类药物的其他耐药机制包括氨基糖苷修饰酶（例如，转移酶）和突变的孔蛋白。\n\n（选项C）参与RNA合成的酶的结构改变是生物体对利福平产生耐药性的机制。 利福平抑制细菌DNA依赖性RNA聚合酶，从而阻止DNA转录成mRNA。\n\n（选项D）细菌过氧化氢酶-过氧化物酶活性降低是分枝杆菌对INH产生耐药性的机制。 分枝杆菌过氧化氢酶-过氧化物酶是INH在分枝杆菌细胞内转化为其活性代谢物的初始酶促转化所必需的； 没有这种酶，INH就无法抑制分枝杆菌分枝菌酸的合成。\n\n（选项E）参与细胞壁多糖合成的酶活性增加是分枝杆菌产生对乙胺丁醇耐药性的方式。 乙胺丁醇特异性干扰分枝杆菌肽聚糖细胞壁合成，可能通过抑制阿拉伯糖基转移酶。 这种药物对分枝杆菌以外的生物体无效。\n\n教学目标：\n- 氨基糖苷类药物链霉素通过灭活30S（小）核糖体亚基来抑制蛋白质合成。\n- 细菌过氧化氢酶-过氧化物酶活性降低是分枝杆菌对异烟肼产生耐药性的机制。\n- 参与RNA合成（DNA依赖性RNA聚合酶）的酶的结构改变是生物体对利福平产生耐药性的机制。"
  },
  "summary": {
    "en": "This question tests the mechanisms of antibiotic resistance in Mycobacterium tuberculosis, specifically focusing on streptomycin resistance. It requires understanding how mutations in ribosomal proteins can lead to resistance against aminoglycosides like streptomycin. \n\nTo solve this question, focus on the resistance pattern provided and recall the mechanism of action of streptomycin. Recognize that streptomycin inhibits protein synthesis by binding to the 30S ribosomal subunit, and therefore, alterations in ribosomal proteins are the most likely cause of resistance.",
    "zh": "这个问题考察了结核分枝杆菌中抗生素耐药性的机制，特别关注链霉素耐药性。 它需要了解核糖体蛋白的突变如何导致对链霉素等氨基糖苷类药物的耐药性。\n\n要解决这个问题，请关注所提供的耐药模式，并回忆链霉素的作用机制。 认识到链霉素通过与30S核糖体亚基结合来抑制蛋白质合成，因此，核糖体蛋白的改变是耐药性的最可能原因。"
  },
  "tags": "Mycobacterium tuberculosis; Tuberculosis meningitis; Antibiotic resistance; Streptomycin; Ribosomal proteins; Infectious diseases; Microbiology; Aminoglycosides; Central nervous system",
  "category": "Micro",
  "question_id": "1310",
  "has_exhibits": false,
  "exhibit_count": 0,
  "exhibit_files": [],
  "folder_path": "C:\\Datas\\usmle\\step1\\clip\\Micro 23\\1310",
  "extracted_at": "2025-11-05T14:52:14.556280",
  "extraction_config": {
    "temperature": 0.1,
    "top_k": 1,
    "prompt_strategy": "standard"
  },
  "translated_at": "2025-11-07T18:06:40.288668",
  "translation_model": "gemini-2.0-flash-lite",
  "embedding_model": "models/embedding-001",
  "embedding_dimension": 768
}